EP3432872

EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    16.3.2017
  • EP published:
    25.8.2021
  • EP application number:
    17770846.8
  • Max expiry date:
    15.3.2037
  • Title:
    EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA

Timeline

Today
16.3.2017EP application
25.8.2021EP Publication

Owner

  • Name:
    Orbus Therapeutics, Inc.
  • Address:
    2475 East Bayshore Road Suite 105, Palo Alto, CA 94303, US

Inventor

  • Name:
    LEVIN, Victor, A.
  • Address:
    Palo Alto, CA 94303, US

Priority

  • Number:
    201662312623 P
  • Date:
    24.3.2016
  • Country:
    US

Classification

  • Categories:
    A61K 31/195, A61K 31/197, A61P 35/04

Upload documents